Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug Interactions for VC005 Tablets in Healthy Adult Subjects
NCT07796191Phase 1Not yet recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Sep 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of VC-005 (3 arms), sponsored by Jiangsu Vcare PharmaTech Co., Ltd. Primary endpoints: Maximum Observed Plasma Concentration and Area Under the Curve From Time Zero to Last Quantifiable Concentration. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
VC-005
Beyond the preview
Go deeper on NCT07796191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07796191.